Olink®Part of Thermo Fisher Scientific
Powerful, NGS-based proteomics - effortlessly uncover meaningful insights
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join the growing global community and consortia of Olink users to empower your biomarker discovery.
Over 3,300 and growing rapidly – covering all major disease areas
Your source for Olink’s terms, privacy policies, and compliance details
Dec 9, 2025
Webinar · 22:11
Sarantis Chlamydas, PhD, Senior Scientific Lead, Olink, part of Thermo Fisher Scientific.